Abstract
The biotechnology industry is a star industry in the 21st century, and the government is actively investing in the development of biotechnology industry. As the field of biotechnology industry is quite extensive, in recent years, the regenerative medicine industry is the most enthusiastic discussion of the topic, especially the stem cell industry is the regenerative medicine industry in the novel technology. However, in the stem cell industry, most companies are only stem cell storage services, but at domestic and abroad have been some stem cell companies began to carry out the development of new stem cells, get good results. As the new stem cells and general new drug development methods are different, most of the new drug is the development of chemical synthesis of drugs, and stem cells of new drugs stem cells as the main component of cell preparations for implant treatment, so the development and specifications are different from the general. Cell preparation is a new technology in the biotechnology industry, there is no standard in Taiwan, the company can become a stem cell new drug company strategy model; therefore, the Gwoxi stem cell company to develop their own set of strategic business model, hoping to take into account operating income and related stem cell research and development of new drugs common goal, so that the company can continue to operate. Therefore, the purpose of this study is to adopt the quantitative analysis method to explore the innovation management strategy of Gwoxi stem cell company. In this study, the paper used to study the important strategies of management and management, and the use of regression analysis as a research method to stem cell management strategies and operating methods have a deeper layer of research. In addition, the purpose of this study is almost the same for customers who need data analysis and find the needs of customers. Therefore, this study suggests that the proposed recommendations will be helpful for the future development of the stem cell industry by academia, industry and government agencies.